Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)

Q: What does CUSIP 21833P301 represent in this 13F holders report?

CUSIP 21833P301 is the security identifier for CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

Q: How many institutions held CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value in Q3 2025?

79 institutional investors reported CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 21833P301

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock, $0.0001 par value
Total 13F shares: 8,624,602
Total 13F value: $109,102,095
Share change: -259,945
Put/Call ratio: 27%
SEC-reported price per share: $12.65
Number of holders: 79
Value change: -$2,067,263
Number of buys: 32
Number of sells: 37
Shares outstanding: 17,685,185

Security key

21833P301

Report period

Q3 2025

Institutions

Top holders

CRBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 Corbus Pharmaceuticals Holdings, Inc. SEC filings Corbus Pharmaceuticals Holdings, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 21833P301

Newer quarter: Q4 2025 Previous quarter: Q2 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

Cormorant Asset Managemen...

Comparable rows

15/15

Latest evidence

30 Jun 2025

13F 13D/G Lead comparable stake: 5.9% 13D/G row: ORBIMED ADVISORS LLC Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 5.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Comparable ownership Top 5

ORBIMED ADVISORS LLC 5.9%

VANGUARD GROUP INC 4.9%

BlackRock, Inc. 2.9%

Cormorant Asset Management, LP 13%

Octagon Capital Advisors LP 6.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F 13D/G Company · OrbiMed Capital LLC 13F 13D/G	5.9% from 13D/G	$8,088,780 1,172,287 shares	—	30 Jun 2025
VANGUARD GROUP INC	13F 13D/G Company · The Vanguard Group 13F 13D/G	4.9% from 13D/G	$4,136,516 599,495 shares	—	30 Jun 2025
BlackRock, Inc.	13D/G 13F Company 13D/G 13F	2.9%	$2,431,622 352,409 shares	$0	30 Jun 2025
Cormorant Asset Management, LP	13F Company 13F	13%	$16,387,500 2,375,000 shares	—	30 Jun 2025
Octagon Capital Advisors LP	13F Company 13F	6.3%	$7,693,500 1,115,000 shares	—	30 Jun 2025
Prosight Management, LP	13F Company 13F	3.3%	$4,001,262 579,893 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

8,624,602

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend